Skip to main content
. 2015 May 4;10(5):e0125597. doi: 10.1371/journal.pone.0125597

Fig 5. Sphingomyelinase activity decreases in Alzheimer’s disease.

Fig 5

aSMase (5A) and nSMase (5B) activities were measured in CSF using fluorescent assays. The data are expressed as the mean ± SEM of the relative fluorescent unit (RFU) per minute using 10 μg protein per assay for CN (n = 70), MCI (n = 40), and AD (n = 29). The asterisk (*) denotes values of P < 0.05 compared with CN.